Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | ERMN | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Ermn (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ERMN mRNA | CTD | PMID:33387578 | ERMN | Human | 6-propyl-2-thiouracil | decreases expression | ISO | Ermn (Rattus norvegicus) | 6480464 | Propylthiouracil results in decreased expression of ERMN mRNA | CTD | PMID:24780913 and PMID:25825206 | ERMN | Human | all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of ERMN mRNA | CTD | PMID:33167477 | ERMN | Human | amiodarone | increases expression | EXP | | 6480464 | Amiodarone results in increased expression of ERMN mRNA | CTD | PMID:19774075 | ERMN | Human | amitrole | decreases expression | ISO | Ermn (Rattus norvegicus) | 6480464 | Amitrole results in decreased expression of ERMN mRNA | CTD | PMID:38685447 | ERMN | Human | antirheumatic drug | decreases expression | EXP | | 6480464 | Antirheumatic Agents results in decreased expression of ERMN mRNA | CTD | PMID:24449571 | ERMN | Human | arsenite(3-) | increases methylation | EXP | | 6480464 | arsenite results in increased methylation of ERMN promoter | CTD | PMID:23974009 | ERMN | Human | benzene | increases expression | EXP | | 6480464 | Benzene results in increased expression of ERMN mRNA | CTD | PMID:19162166 | ERMN | Human | benzo[a]pyrene | multiple interactions | ISO | Ermn (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ERMN mRNA | CTD | PMID:27858113 | ERMN | Human | benzo[a]pyrene | decreases methylation | EXP | | 6480464 | Benzo(a)pyrene results in decreased methylation of ERMN promoter | CTD | PMID:27901495 | ERMN | Human | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of ERMN exon | CTD | PMID:27901495 | ERMN | Human | benzo[b]fluoranthene | multiple interactions | ISO | Ermn (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ERMN mRNA | CTD | PMID:27858113 | ERMN | Human | bisphenol A | decreases expression | ISO | Ermn (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of ERMN mRNA | CTD | PMID:25181051 | ERMN | Human | bisphenol A | increases expression | ISO | Ermn (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of ERMN mRNA | CTD | PMID:34947998 | ERMN | Human | bisphenol F | increases expression | ISO | Ermn (Mus musculus) | 6480464 | bisphenol F results in increased expression of ERMN mRNA | CTD | PMID:36706583 | ERMN | Human | Brodifacoum | decreases expression | ISO | Ermn (Rattus norvegicus) | 6480464 | bromfenacoum results in decreased expression of ERMN protein | CTD | PMID:28903499 | ERMN | Human | carbon nanotube | decreases expression | ISO | Ermn (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | ERMN | Human | chrysene | multiple interactions | ISO | Ermn (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ERMN mRNA | CTD | PMID:27858113 | ERMN | Human | copper atom | increases expression | ISO | Ermn (Rattus norvegicus) | 6480464 | Copper deficiency results in increased expression of ERMN mRNA | CTD | PMID:26033743 | ERMN | Human | copper(0) | increases expression | ISO | Ermn (Rattus norvegicus) | 6480464 | Copper deficiency results in increased expression of ERMN mRNA | CTD | PMID:26033743 | ERMN | Human | copper(II) sulfate | decreases expression | EXP | | 6480464 | Copper Sulfate results in decreased expression of ERMN mRNA | CTD | PMID:19549813 | ERMN | Human | Cuprizon | decreases expression | ISO | Ermn (Rattus norvegicus) | 6480464 | Cuprizone results in decreased expression of ERMN mRNA | CTD | PMID:26577399 and PMID:27523638 | ERMN | Human | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | ERMN | Human | fenvalerate | increases expression | ISO | Ermn (Rattus norvegicus) | 6480464 | fenvalerate results in increased expression of ERMN mRNA | CTD | PMID:30307764 | ERMN | Human | gentamycin | decreases expression | ISO | Ermn (Rattus norvegicus) | 6480464 | Gentamicins results in decreased expression of ERMN mRNA | CTD | PMID:33387578 | ERMN | Human | glycidol | decreases expression | ISO | Ermn (Rattus norvegicus) | 6480464 | glycidol results in decreased expression of ERMN mRNA | CTD | PMID:24395379 | ERMN | Human | methylmercury chloride | decreases expression | EXP | | 6480464 | methylmercuric chloride results in decreased expression of ERMN mRNA | CTD | PMID:28001369 | ERMN | Human | nickel atom | increases expression | EXP | | 6480464 | Nickel results in increased expression of ERMN mRNA | CTD | PMID:23195993 and PMID:25583101 | ERMN | Human | ozone | multiple interactions | EXP | | 6480464 | [Air Pollutants results in increased abundance of Ozone] which affects the expression of ERMN mRNA | CTD | PMID:35430440 | ERMN | Human | paracetamol | decreases expression | ISO | Ermn (Rattus norvegicus) | 6480464 | Acetaminophen results in decreased expression of ERMN mRNA | CTD | PMID:33387578 | ERMN | Human | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | ERMN | Human | tetraphene | multiple interactions | ISO | Ermn (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ERMN mRNA | CTD | PMID:27858113 | ERMN | Human | Theaflavin 3,3'-digallate | affects expression | EXP | | 6480464 | theaflavin-3 and 3'-digallate affects the expression of ERMN mRNA | CTD | PMID:34925699 | ERMN | Human | trichloroethene | decreases methylation | ISO | Ermn (Rattus norvegicus) | 6480464 | Trichloroethylene results in decreased methylation of ERMN gene | CTD | PMID:27618143 | ERMN | Human | trichloroethene | decreases expression | ISO | Ermn (Rattus norvegicus) | 6480464 | Trichloroethylene results in decreased expression of ERMN mRNA | CTD | PMID:33387578 | ERMN | Human | valproic acid | increases methylation | EXP | | 6480464 | Valproic Acid results in increased methylation of ERMN gene | CTD | PMID:29154799 | ERMN | Human | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of ERMN mRNA | CTD | PMID:26272509 and PMID:28001369 | ERMN | Human | valproic acid | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ERMN mRNA | CTD | PMID:27188386 | ERMN | Human | vorinostat | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ERMN mRNA | CTD | PMID:27188386 | |